- Home
- LIF vs TERN Comparison
LIF vs TERN Comparison
Compare LIF & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LIF | TERN |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.7B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | LIF | TERN |
|---|---|---|
| Price | $53.97 | $37.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $89.64 | $48.60 |
| AVG Volume (30 Days) | 1.2M | ★ 2.3M |
| Earning Date | 03-02-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $459,031,000.00 | N/A |
| Revenue This Year | $31.03 | N/A |
| Revenue Next Year | $31.66 | N/A |
| P/E Ratio | $141.66 | ★ N/A |
| Revenue Growth | ★ 33.86 | N/A |
| 52 Week Low | $29.62 | $1.87 |
| 52 Week High | $112.54 | $48.26 |
Technical Indicators
Market Signals| Indicator | LIF | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 39.95 | 52.55 |
| Support Level | $52.22 | $34.99 |
| Resistance Level | $61.58 | $38.97 |
| Average True Range (ATR) | 2.86 | 1.97 |
| MACD | -0.29 | 0.04 |
| Stochastic Oscillator | 13.07 | 61.76 |
Price Performance
Historical ComparisonAbout LIF Life360 Inc.
Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.